Amgen Dives 9% Despite 'Remarkable' Results For Obesity Drug – Investor's Business Daily

Business News

  1. Amgen Dives 9% Despite ‘Remarkable’ Results For Obesity Drug  Investor’s Business Daily
  2. New Obesity Drug MariTide Helps Patients Lose Up to 20% of Weight, Early Data Shows  The New York Times
  3. Amgen Obesity Drug Cut Weight In Closely Watched Study  The Wall Street Journal
  4. Amgen Stock Dives After Weight-Loss Drug Data. Here’s What to Know.  Barron’s
  5. Amgen’s monthly obesity drug matches competition in phase 2, but investors are unimpressed  Fierce Biotech

Source: Business News

/by